Recursion Pharmaceuticals, Inc.
RXRX
$4.94
$0.163.35%
NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 10.70% | 68.89% | 51.79% | 10.41% | 16.87% |
| Total Receivables | 755.34% | 1,674.68% | 1,489.08% | -28.73% | -17.21% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -11.13% | -21.46% | 62.73% | 120.95% | 105.93% |
| Total Current Assets | 12.40% | 70.00% | 63.02% | 15.50% | 21.20% |
|
|
|||||
| Total Current Assets | 12.40% | 70.00% | 63.02% | 15.50% | 21.20% |
| Net Property, Plant & Equipment | 23.88% | 67.55% | 94.06% | 32.32% | 25.36% |
| Long-term Investments | 215.56% | 203.73% | 185.99% | -1.32% | -13.98% |
| Goodwill | 215.56% | 203.73% | 185.99% | -1.32% | -13.98% |
| Total Other Intangibles | 793.27% | 915.21% | 821.59% | -13.60% | -10.63% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 67.25% | 161.66% | 137.85% | -10.21% | -10.36% |
| Total Assets | 67.86% | 133.98% | 121.60% | 15.17% | 16.37% |
|
|
|||||
| Total Accounts Payable | 413.40% | 390.44% | 446.75% | -47.01% | 80.35% |
| Total Accrued Expenses | 163.65% | 121.72% | 92.23% | 120.24% | -4.23% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 22.54% | 234.15% | 260.89% | 171.93% | 183.56% |
| Total Finance Division Other Current Liabilities | 20.82% | 9.20% | 53.42% | -22.29% | -53.32% |
| Total Other Current Liabilities | 20.82% | 9.20% | 53.42% | -22.29% | -53.32% |
| Total Current Liabilities | 90.54% | 92.07% | 101.21% | 15.69% | -24.46% |
|
|
|||||
| Total Current Liabilities | 90.54% | 92.07% | 101.21% | 15.69% | -24.46% |
| Long-Term Debt | -- | 1,435.57% | -37.87% | -9.86% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -27.02% | 27.95% | 97.14% | 65.14% | 59.56% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 371.24% | 313.61% | 166.41% | -64.59% | -12.52% |
| Total Liabilities | 100.20% | 136.95% | 117.50% | 4.71% | -3.20% |
|
|
|||||
| Common Stock & APIC | 54.00% | 74.88% | 72.86% | 35.38% | 39.22% |
| Retained Earnings | -56.12% | -54.27% | -47.92% | -43.19% | -47.97% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 57.27% | 132.82% | 123.28% | 19.77% | 24.63% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 57.27% | 132.82% | 123.28% | 19.77% | 24.63% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 57.27% | 132.82% | 123.28% | 19.77% | 24.63% |
|
|
|||||